IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.530
-0.030 (-1.92%)
At close: Apr 28, 2026, 4:00 PM EDT
1.530
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
IN8bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 9.65 | 12.64 | 13.51 | 14.46 | 7.31 | |
| Research & Development | 10.21 | 16.96 | 16.83 | 14.06 | 7.35 | |
| Operating Expenses | 19.86 | 29.6 | 30.34 | 28.52 | 14.65 | |
| Operating Income | -19.86 | -29.6 | -30.34 | -28.52 | -14.65 | |
| Interest & Investment Income | 0.42 | 0.23 | - | - | - | |
| Other Non Operating Income (Expenses) | - | - | 0.33 | - | - | |
| EBT Excluding Unusual Items | -19.44 | -29.37 | -30.01 | -28.52 | -14.65 | |
| Merger & Restructuring Charges | - | -1.07 | - | - | - | |
| Pretax Income | -19.44 | -30.44 | -30.01 | -28.52 | -14.65 | |
| Net Income | -19.44 | -30.44 | -30.01 | -28.52 | -14.65 | |
| Net Income to Common | -19.44 | -30.44 | -30.01 | -28.52 | -14.65 | |
| Shares Outstanding (Basic) | 4 | 2 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 4 | 2 | 1 | 1 | 0 | |
| Shares Change (YoY) | 145.07% | 79.30% | 42.43% | 110.32% | 191.59% | |
| EPS (Basic) | -4.44 | -17.05 | -30.14 | -40.81 | -44.09 | |
| EPS (Diluted) | -4.44 | -17.05 | -30.14 | -40.81 | -44.09 | |
| Free Cash Flow | -12.71 | -24.34 | -23.94 | -27.83 | -13.82 | |
| Free Cash Flow Per Share | -2.91 | -13.63 | -24.05 | -39.81 | -41.58 | |
| EBITDA | -18.09 | -27.76 | -28.5 | -27.91 | -14.03 | |
| D&A For EBITDA | 1.77 | 1.84 | 1.83 | 0.61 | 0.63 | |
| EBIT | -19.86 | -29.6 | -30.34 | -28.52 | -14.65 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.